BioCentury
ARTICLE | Company News

Allos cancer news

June 2, 2003 7:00 AM UTC

ALTH restructured in order to focus on a planned third quarter rolling NDA submission for its RSR13 radiosensitizer to treat brain metastases from breast cancer. The company reduced its headcount to 6...